Skip to content
Search

Latest Stories

FINANCE: Planning for a year’s prosperity

By Umesh Modi

With the start of the new year and the end of the tax year around the corner, it is important to start planning for potential tax liabilities. There are numerous ways in which you can mitigate your tax liabilities through various reliefs available along with proper tax planning.


Income tax

  • Use your personal tax reliefs
  • Capital and the related income can normally be transferred between husband and wife or civil partners without any tax liabilities. Such transfers must be outright gifts and can be made free of both capital gains tax and inheritance tax
  • Consider paying your spouse/civil partner/children a salary for working in your business
  • Consider taking your spouse/civil partner into partnership
  • Consider one-off or recurring donations to charity

Benefits in kind

  • Keep records of business trips showing the date, mileage, and purpose of trip to satisfy HM Revenue & Customs queries
  • Consider reimbursing your employer for the full cost of private petrol to prevent the car fuel charge applying
  • Remember that no tax is charged on beneficial loans totalling less than £10,000 per employee

Pensions

  • Check that your pension arrangements are adequate, especially if you are self-employed or not in a company scheme
  • There is no limit on the amount that may be contributed to a registered pension scheme. However, there are limits on the level of tax relievable contributions that can be made. The maximum amount on which an individual can claim tax relief in any tax year is the greater of the individual’s UK relevant earnings or £3,600, subject to the appropriate annual allowance (contributions in excess of the annual allowance are likely to give rise to a tax charge).
  • Employees in a company scheme may consider paying additional voluntary contributions to help boost their final pension or may consider contributing to any other registered pension scheme.

Capital gains tax

  • You are entitled to £12,000 of net gains free of tax (2019-20). Plan disposals to make use of this exemption
  • Consider deferring disposals until after 5 April to delay CGT payment by a full year
  • Consider the timing of disposals to take advantage of any otherwise unused basic rate income tax band, attracting tax at the lower rate of 10%
  • If you intend to retire from business in the next few years, plan ahead to minimise tax on disposal of your business or family company
  • If you have more than one home, consider making or revising an election to determine which one will qualify for the CGT exemption
  • Claim losses on assets that have become worthless
  • Consider EIS deferral relief, which allows you to defer gains on disposal of any chargeable asset against investment in new ordinary shares in a qualifying unquoted trading company.

Inheritance tax

  • Review your estate planning strategy
  • Review your Will
  • Consider lifetime gifts to individuals or trusts (gifts to spouses are exempt)
  • Maximise business property relief and agricultural property relief
  • Life assurance policies can be used as a way of making gifts to beneficiaries, and also to build up sufficient money to pay any IHT that may eventually become due
  • The annual £3,000 exemption applies to both husband and wife or civil partners and can be carried forward for one year, but then used only if the exemption for the later year is utilised
  • Other reliefs are: £250 small gift exemption, marriage gifts exemption, and gifts for charities, national purposes, public benefit, and political parties

Year-end tax planning

This planning centers on the accounting year end rather than the tax year end:

  • Defer income/advance expenditure
  • Companies may defer sales of chargeable assets until after the year end, thereby deferring capital gains
  • Sole traders and partnerships may consider advancing the sale of chargeable assets if current year capital gains annual exemptions have not been used
  • If your business is seasonal, consider changing your accounting date. The tax rules associated with such a change are complex and great care on the selection of an alternative accounting date is required
  • Accelerate bonuses to staff and directors
  • Make extra employers’ contributions to pension schemes
  • If you are thinking of embarking on a new business venture, bring forward the commencement date to offset any initial losses against current year’s business profits
  • Gains made on the sale of business assets may be rolled over on certain classes of business asset against purchases of replacement assets. Consider whether you need to bring forward the purchase of a replacement asset to enable this relief to be used
  • Remember the annual investment allowance is claimable on most plant and machinery

Dividend v bonus

  • Consider the timing of dividends and bonuses regarding the personal tax position of company shareholders
Source: Practice Track

This article is based on current legislation and practice and is for guidance only. Specific professional advice should be taken before acting on matters mentioned here. Umesh Modi BA ACA is a Chartered Accountant and Tax Advisor, and a partner at Silver Levene LLP. He can be contacted on 020 7383 3200 or umesh.modi@silverlevene.co.uk

More For You

How to leverage data to drive pharmacy growth

Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy.

Pharmacy challenges: How data can help spot the ‘elephant in the room’

Adopting new technologies is vital for moving pharmacy forward — but are you fully harnessing the data these tools generate?

“Being able to utilise, manage, and interpret the data these technologies provide can help add more value to your business,” said Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy, while speaking at the recent Pharmacy Business Conference.

Keep ReadingShow less
Branded OTC products can boost pharmacy revenue and promote self-care, says PAGB CEO

Michelle Riddalls

How branded OTC products can help struggling community pharmacies - PAGB chief explains

Branded over-the-counter (OTC) products could play a vital role in promoting self-care and supporting the sustainability of community pharmacies, said Michelle Riddalls, CEO of PAGB – the consumer healthcare association – during the recent Pharmacy Business Conference.

Riddalls emphasised that OTC medicines not only enable consumers to better manage their health through self-care but also offer pharmacies an opportunity to increase revenue, particularly during a time of mounting financial pressure.

Keep ReadingShow less
How Peptides Are Transforming Modern Drug Development

Modern Drug Development

How Peptides Are Transforming Modern Drug Development

The pharmaceutical industry is rapidly evolving, embracing new technologies and methodologies. Peptides are emerging as a crucial component in this transformation, offering innovative solutions to drug development. This shift is not only reshaping how drugs are discovered but also enhancing their efficacy and safety.

In recent years, the pharmaceutical landscape has undergone significant changes, driven by advancements in technology and scientific understanding. One of the most promising areas of innovation is the use of peptides in drug development. These short chains of amino acids have proven to be versatile tools, capable of targeting specific cells or molecules with high precision. In this context, certain bpc 157 peptide research peptides have been highlighted for their potential applications in various therapeutic areas, showcasing the promise that peptides hold for modern pharmaceutical studies.

Keep ReadingShow less
Off-patent medicines could save NHS millions—but only if UK remains attractive to suppliers - BGMA

BGMA chief executive Mark Samuels urges government to back off-patent medicines ahead of Life Sciences Plan release.

UK risks losing millions in NHS savings without stronger support for generics - BGMA

The British Generic Manufacturers Association (BGMA) has called on the government to create a more supportive environment for the generics and biosimilars sector, warning that the UK risks missing out on significant NHS savings arising from new off-patent medicines.

According to the BGMA, 31 medicines are due to lose patent protection between January and June 2025, with a further 28 set to follow in the second half of the year.

Keep ReadingShow less
Support for generic medicines manufacturers key to affordable healthcare- Teva UK director

Teva UK sounds alarm on accelerating consolidation of critical generic medicines

Photo credit: gettyimages

Exclusive: Teva UK calls for inclusion of generic manufacturers in policy talks

A healthy and vibrant generics marketplace supports not only patients but also contributes billions of pounds in savings to the drugs bill. However, growing pressures on generic medicine manufacturers could threaten this vital part of the healthcare ecosystem, warns Ryan Ruscoe, senior director of generics and OTC at Teva UK.

Speaking exclusively to Pharmacy Business, Ruscoe stressed the urgent need to address supply chain vulnerabilities, particularly for critical generic medicines.

Keep ReadingShow less